Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome

Human Pathology

Volumn 42, Issue 2, 2011, Pages 227-235

  Kavoura, Evangelia ^a   Gakiopoulou, Hariklia ^a   Paraskevakou, Helen ^a   Marinaki, Smaragdi ^b   Agrogiannis, George ^a   Stofas, Anastasios ^a   Boletis, Ioannis ^b   Patsouris, Efstratios ^a   Lazaris, Andreas C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Nephrotic syndrome; Podocalyxin; Podocyte

Indexed keywords

PODOCALYXIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOGENESIS; PODOCYTOPATHY; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PODOCYTES; SIALOGLYCOPROTEINS; YOUNG ADULT;

EID: 78751591370     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.05.028     Document Type: Article

References (41)

1. Barisoni L., Schnaper H.W., and Kopp J.B. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephritic diseases Clin J Am Soc Nephrol 2 2007 529 542
2. Barisoni L., Schnaper H.W., and Kopp J.B. Advances in the biology and genetics of the podocytopathies. Implications for diagnosis and therapy Arch Pathol Lab Med 133 2009 201 216
3. Chen C., and Chen H. Advances on the podocyte foot process and glomerulosclerosis Acta Nephrologica 18 2004 145 150
4. Barisoni L., and Mundel P. Podocyte biology and the emerging understanding of podocyte diseases Am J Nephrol 23 2003 353 360
5. Kerjaschki D., Sharkey D.J., and Farquhar M.G. Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell J Cell Biol 98 1984 1591 1596
6. Kershaw D.B., Wiggins J.E., Wharram B.L., and Wiggins R.C. Assignment of the human podocalyxin-like protein (PODXL) gene to 7q32-q33 Genomics 45 1997 239 240
7. Takeda T. Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na/H-exchanger regulatory factor 2 and ezrin Clin Exp Nephrol 7 2003 260 269
8. Takeda T., Go W.Y., Orlando R.A., and Farquhar M.G. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in madin-darby canine kidney cells Mol Biol Cell 11 2000 3219 3232
9. Pavenstadt H., Kriz W., and Kretzler M. Cell biology of the glomerular podocyte Physiol Rev 83 2003 253 307
10. Tesar V., and Zima T. Recent progress in the pathogenesis of nephrotic proteinuria Crit Rev Clin Lab Sci 45 2008 139 220
11. Levidiotis V., and Power D.A. New insights into the molecular biology of the glomerular filtration barrier and associated disease Nephrology 10 2005 157 166
12. Schmieder S., Nagai M., Orlando R.A., Takeda T., and Farquhar M.G. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells J Am Soc Nephrol 15 2004 2289 2298
13. Nielsen J.S., and McNagny K.M. The role of podocalyxin in health and disease J Am Soc Nephrol 20 2009 1669 1676
14. Thomas S.N., Schnaar R.L., and Konstantopoulos K. Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells Am J Physiol Cell Physiol 296 2009 C505 C513
15. Yasuoka H., Tsujimoto M., and Hirokawa M. Podocalyxin expression in undifferentiated thyroid carcinomas J Clin Pathol 61 2008 1228 1229
16. Kelley T.W., Huntsman D., and McNagny K.M. Podocalyxin A marker of blasts in acute leukemia Am J Clin Pathol 124 2005 134 142
17. Casey G., Neville P.J., and Liu X. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness Hum Mol Genet 15 2006 735 741
18. Sizemore S., Cicek M., and Sizemore N. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin Cancer Res 67 2007
19. Koop K., Eikmans M., and Baelde H.J. Expression of podocyte-associated molecules in acquired human kidney diseases J Am Soc Nephrol 14 2003 2063 2071
20. Wagrowska-Danilewicz M., Stasikowska O., and Danilewicz M. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome Pol J Pathol 57 2006 17 21
21. Hara M., Yanagihara T., and Takada T. Podocalyxin on the glomerular epithelial cells is preserved well in various glomerular diseases Nephron 67 1994 123 124
22. Barisoni L., Kriz W., Mundel P., and D'Agati V. The dysregulated podocyte phenotype. A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy J Am Soc Nephrol 10 1999 51 61
23. Li Y., Kang Y.S., and Dai C. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria Am J Pathol 172 2008 299 308
24. Bariety J., Bruneval P., Hill G.S., Mandet C.h., Jacquot C.h., and Meyrier A. Transdifferentiation of epithelial glomerular cells J Am Soc Nephrol 14 2003 S42 S47
25. D'Agati V. The spectrum of FSGS: new insights Curr Opin Nephro Hypertens 17 2008 271 281
26. Yoshida S., Nagase M., and Shibata S. Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK 108 2008 e57 e68
27. Galeano B., Klootwijk R., and Manoli I. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine J Clin Invest 117 2007 1585 1594
28. Saha T.C., and Singh H. Minimal change disease: a review South Med J 99 2006 1264 1270
29. Lahdenkari A.T., Lounatmaa K., and Patrakka J. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria J Am Soc Nephrol 15 2004 2611 2618
30. Kobayashi T., Notoya M., and Shinosaki T. Cortactin interacts with podocalyxin and mediates morphological change of podocytes through its phosphorylation Nephron Exp Nephrol 113 2009 e89 e96
31. Abbate M., Zoja C., and Morigi M. Transforming growth factor-b1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins Am J Pathol 161 2002 2179 2219
32. Ferrario F., and Rastaldi M.P. Histopathological atlas of renal diseases: minimal change disease and focal segmental glomerulosclerosis J Nephrol 18 2005 1 4
33. Schwartz M.M. Focal and segmental glomerulosclerosis J.C. Jennette, J.L. Olson, M.M. Schwartz, F.G. Silva, 6th Heptinstall's pathology of the kidney 2007 Lippincott Williams & Wilkins 156 203
34. Nangaku M., Shankland S.J., and Couser W.G. Cellular response to injury in membranous nephropathy J Am Soc Nephrol 16 2005 1195 1204
35. Ronco P., and Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men Seminars in Immunopathology 29 2007 1863 2297
36. Ronco P., and Debiec H. New insights in the pathogenesis of membranous glomerulonephritis Curr Opin Nephro Hypertens 15 2006 258 263
37. Habara P., Mareckova H., and Sopkova Z. A novel method for estimation of podocyte injury: podocalyxin-positive elements in urine Folia Biologica (Praha) 54 2008 162 167
38. Hara M., Yanagihara T., and Kihara I. Urinary podocytes in primary FSGS Nephron 89 2001 342 347
39. Bariéty J., Bruneval P., and Hill G. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation J Am Soc Nephrol 12 2001 261 274
40. Hara M., Yanagihara T., Kihara I., Higashi K., Fujimoto K., and Kajita T. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury J Am Soc Nephrol 16 2005 408 416
41. Shankland S.J., Pippin J.W., and Couser W.G. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro Kidney Int 56 1999 538 548